Revenue: The sum of all revenue fields included for a company's operating activities.
Travere Therapeutics, Inc. (TVTX) had Revenue of $81.73M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$81.73M |
$-41.23M |
|
$4.68M |
|
$77.05M |
|
$124.41M |
|
$-42.67M |
|
$1.49M |
|
$-41.19M |
|
$-41.19M |
|
$-41.23M |
|
$-41.23M |
|
$-41.23M |
|
$-41.23M |
|
$-42.67M |
|
$-29.87M |
|
88.36M |
|
88.36M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$374.17M |
|
$4.85M |
|
$174.63M |
|
$548.80M |
|
$182.46M |
|
$310.66M |
|
$333.52M |
|
$515.98M |
|
$32.82M |
|
$-70.99M |
|
$32.82M |
|
88.79M |
|
| Cash Flow Statement Financials | |
$-42.19M |
|
$41.29M |
|
$3.72M |
|
$58.53M |
|
$61.90M |
|
$3.36M |
|
$11.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
0.90 |
|
11.56 |
|
94.28% |
|
-52.21% |
|
-52.21% |
|
-- |
|
-50.39% |
|
-50.44% |
|
$-42.19M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.19 |
|
2.38 |
|
37.86 |
|
-125.60% |
|
58.07% |
|
-7.51% |
|
-12.00% |
|
$0.37 |
|
$-0.48 |
|
$-0.48 |
|